Ireland
--:--IST
Recruiting Not applicable

Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis

NCT05451901 · tracked via the Priya Life Science Japan tracker
Phase
Not applicable
Started
2022-07-29
Last updated
2022-10-27

Condition(s) studied

Pancreatic Fluid CollectionWalled-off NecrosisPancreatitis, Acute NecrotizingPancreatic Pseudocyst

Investigational drug(s) / intervention(s)

Immediate necrosectomyStep-up approach

Immediate necrosectomy: Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the immediate necrosectomy group, endoscopic necrosectomy (EN) will be performed in the same session of EUS-guided drainage using a gastroscope. The endoscope is inserted into the WON cavity through the LAMS, and necrotic tissue is removed using biopsy forceps, snare, or basket catheter. The EN procedures will be repeated until clinical improvement.

Step-up approach: Endoscopic ultrasonography (EUS)-guided drainage will be conducted within 72 hours from randomization. A convex-type echoendoscope is advanced to the stomach or duodenum, and the walled-off necrosis (WON) is visualized and punctured under EUS guidance. A lumen-apposing metal stent (LAMS), such as Hot AXIOS system (Boston Scientific Japan, Tokyo, Japan), is recommended for the initial EUS-guided drainage. For the step-up approach group, an additional interventional procedure will be withheld for 72-96 hours after initial EUS-guided drainage. In cases without clinical improvement after 72-96 hours, additional drainage will be permitted, which includes increasing the number of stents, additional EUS-guided drainage, and performing percutaneous drainage (step-up treatment). Insufficient improvement even after two times of step-up treatment allows subsequent endoscopic necrosectomy (EN).

Study summary

Walled-off necrosis (WON) is a pancreatic fluid collection, which contains necrotic tissue after four weeks of the onset of acute pancreatitis. Interventions are required to manage patients with infected WON, for which endoscopic ultrasonography (EUS)-guided drainage has become a first-line treatment modality. For patients who are refractory to EUS-guided drainage, the step-up treatment including endoscopic necrosectomy (EN) and/or additional drainage is considered to subside the infection. Recent evidence suggests that EN immediately after EUS-guided drainage may shorten treatment duration without increasing adverse events. In this randomized trial, the investigators will compare treatment duration between EN immediately after EUS-guided drainage versus the step-up approach in patients with symptomatic WON.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients with WON defined according to the revised Atlanta classification * The longest diameter of WON is 4 cm or larger * Patients with at least one out of the following conditions; signs of infection, gastrointestinal symptoms, abdominal symptoms, obstructive jaundice * Patients who need drainage for WON * Age of 18 years or older * Patients or their representatives provide informed consent * Patients who visit or are hospitalized at the participating institutions Exclusion Criteria: * WON inaccessible by EUS-guided approach * AXIOS stent has already been placed into the WON prior to the enrollment * Severe coagulopathy; Platelet count \< 50,000/mm3 or prothrombin time international normalized ratio (PT-INR) \>1.5 * Patients on antithrombotic agents which cannot be managed according to the "guideline for gastroenterological endoscopy in patients undergoing antithrombotic treatment (Dig Endosc. 2014 Jan;26(1):1-14.)" * Patients who cannot tolerate endoscopic procedures * Pregnant women * Patients considered inappropriate for inclusion by investigators

Primary outcome measure(s)

  • Time to clinical success from randomization — Six months
    Clinical success is defined as 1) a decrease in the WON size to 3 cm or less and 2) an improvement of more than two out of the three following inflammatory markers; body temperature, white blood cell count, and C-reactive protein.

Trial sites (21)

FacilityCityRegionStatus
Department of Gastroenterology, The University of Tokyo Hospital Bunkyō-Ku Tokyo Not Yet Recruiting
Department of Gastroenterology, Graduate School of Medicine, Juntendo University Bunkyō-Ku Tokyo Recruiting
Department of Gastroenterology, Aichi Medical University Aichi Japan Recruiting
Department of Gastroenterology, Graduate School of Medicine, Chiba University Chiba Japan Recruiting
Department of Gastroenterology, Gifu Municipal Hospital Gifu Japan Recruiting
Department of Gastroenterology, Gifu Prefectural General Medical Center Gifu Japan Recruiting
First Department of Internal Medicine, Gifu University Hospital Gifu Japan Not Yet Recruiting
Division of Gastroenterology and Hepatobiliary and Pancreatic Diseases, Department of Internal Medicine, Hyogo Medical University Hyōgo Japan Recruiting
Department of Gastroenterology and Neurology, Faculty of Medicine, Kagawa University Kagawa Japan Recruiting
Digestive and Lifestyle Diseases, Kagoshima University Graduate School of Medical and Dental Sciences Kagoshima Japan Recruiting
Department of Gastroenterology, Kameda Medical Center Kamogawa Japan Recruiting
Department of Gastroenterological Endoscopy, Kanazawa Medical University Kanazawa Japan Not Yet Recruiting
Department of Gastroenterology and Hepatology, Saitama Medical Center, Saitama Medical University Kawagoe Japan Not Yet Recruiting
Department of Gastroenterology, Teikyo University Mizonokuchi Hospital Kawasaki Japan Not Yet Recruiting
Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine Kobe Japan Recruiting
Department of Gastroenterology, Yuuai Medical Center Okinawa Japan Recruiting
2nd Department of Internal Medicine, Osaka Medical College Osaka Japan Not Yet Recruiting
Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine Ōsaka-sayama Japan Not Yet Recruiting
Department of Gastroenterology and Hepatology, Hokkaido University Hospital Sapporo Japan Recruiting
Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine Tokyo Japan Not Yet Recruiting
Third Department of Internal Medicine, University of Toyama Toyama Japan Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05451901 on ClinicalTrials.gov ↗ ← All trials in Japan